切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2016, Vol. 05 ›› Issue (05) : 281 -284. doi: 10.3877/cma.j.issn.2095-3232.2016.05.003

所属专题: 文献

专家论坛

原发性肝癌外科治疗进展
焦作义1,(), 俞泽元1   
  1. 1. 730030 兰州大学第二医院普通外科一科
  • 收稿日期:2016-06-12 出版日期:2016-10-10
  • 通信作者: 焦作义
  • 基金资助:
    中央高校疾病科研项目重大培育项目(lzujbky-2013-m04)

Progress of surgical treatment for primary liver cance

Zuoyi Jiao1(), Zeyuan Yu1   

  • Received:2016-06-12 Published:2016-10-10
  • Corresponding author: Zuoyi Jiao
引用本文:

焦作义, 俞泽元. 原发性肝癌外科治疗进展[J]. 中华肝脏外科手术学电子杂志, 2016, 05(05): 281-284.

Zuoyi Jiao, Zeyuan Yu. Progress of surgical treatment for primary liver cance[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2016, 05(05): 281-284.

[1]
Siegel RL, Fedewa SA, Miller KD, et al. Cancer statistics for Hispanics/Latinos, 2015[J]. CA Cancer J Clin, 2015, 65(6):457-480.
[2]
Rahbari NN, Mehrabi A, Mollberg NM, et al. Hepatocellular carcinoma: current management and perspectives for the future[J]. Ann Surg, 2011, 253(3):453-469.
[3]
Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome[J]. Liver Transpl, 2004, 10(2 Suppl 1):S39-45.
[4]
Llovet JM, Di Bisceglie AM, Bruix J, et a1.Design and endpoints of clinical trials in hepatocellular carcinoma[J].J Natl Cancer Inst, 2008, 100(10):698-711.
[5]
Nishida S, Levi DM, Tz akis AG. Liver natural killer cell inoculum for liver transplantation with hepatocellular carcinoma[J]. Curr Opin Organ Transplant, 2013, 18(6):690-694.
[6]
Eguchi S, Kanematsu T, Arii S, et al. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey[J]. Surgery, 2008, 143(4):469-475.
[7]
Fan ST. Precise hepatectomy guided by the middle hepatic vein[J]. Hepatobiliary Pancreat Dis Int, 2007, 6(4):430-434.
[8]
董家鸿, 黄志强.精准肝切除——21世纪肝脏外科新理念[J].中华外科杂志,2009,47(21):1601-1605.
[9]
Lee KT, Wang SN, Su RW, et al. Is wider surgical margin justified for better clinical outcomes in patients with resectable hepatocellular carcinoma?[J]. J Formos Med Assoc, 2012, 111(3):160-170.
[10]
Ker CG, Chen HY, Chen HJ, et al. Challenge of safety margin in laparoscopic liver resection for hepatocellular carcinoma[J]. Formos J Surg, 2014, 47(5): 183-188.
[11]
Hu W, Pang X, Guo W, et al. Relationship of different surgical margins with recurrence-free survival in patients with hepatocellular carcinoma[J]. Int J Clin Exp Pathol, 2015, 8(3):3404-3409.
[12]
Arnaoutakis DJ, Mavros MN, Shen F, et al. Recurrence patterns and prognostic factors in patients with hepatocellular carcinoma in noncirrhotic liver: a multi-institutional analysis[J]. Ann Surg Oncol, 2014, 21(1): 147-154.
[13]
Wakabayashi H, Ushiyama T, Ishimura K, et al. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions [J]. J Surg Oncol, 2003, 82(2):98-103.
[14]
Yasuda S, Nomi T, Hokuto D, et al. Huge hepatocellular carcinoma with multiple intrahepatic metastases: an aggressive multimodal treatment[J]. Int J Surg Case Rep, 2015(16):44-47.
[15]
Seshadri RM, Baker EH, Templin M, et al. Outcomes of surgical resection and loco-regional therapy in patients with stage 3A hepatocellular carcinoma: a retrospective review from the national cancer database[J]. HPB, 2015, 17(11): 964-968.
[16]
Sugawara Y, Kokudo N. Surgical treatment of hepatocellular carcinoma: comparison of resection and transplantation[J]. Oncology, 2008, 75 Suppl 1:119-123.
[17]
Lee HS, Choi GH, Joo DJ, et al. The clinical behavior of transplantable recurrent hepatocellular carcinoma after curative resection: implications for salvage liver transplantation[J]. Ann Surg Oncol, 2014, 21(8):2717-2724.
[18]
Kobayashi T, Ishiyama K, Ohdan H. Prevention of recurrence after curative treatment for hepatocellular carcinoma[J]. Surg Today, 2013, 43(12):1347-1354.
[19]
孙建,简志祥,区应亮,等.肝癌根治性切除术后早期复发时限和模式的确定及其对预后的影响[J].实用医学杂志,2011,27(10):1748-1750.
[20]
Zhong JH, Zhong QL, Li LQ, et al. Adjuvant and chemopreventive therapies for resectable hepatocellular carcinoma: a literature review[J]. Tumour Biol, 2014, 35(10):9459-9468.
[21]
Zheng Z, Liang W, Wang D, et al. Adjuvant chemotherapy for patients with primary hepatocellular carcinoma: a meta-analysis[J]. Int J Cancer, 2015, 136(6):E751-759.
[22]
Andreou A, Vauthey JN, Cherqui D, et al. Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy[J]. J Gastrointest Surg, 2013, 17(1):66-77.
[23]
吕毅,张谞丰.肝细胞肝癌的多学科协作组概念及其实践[J/CD].中华肝脏外科手术学电子杂志,2013,2(1):1-3.
[1] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 939-944.
[2] 李辉, 吴奇, 张子琦, 张晗, 王仿, 许鹏. 日间全膝关节置换术早期疗效及标准化流程探索[J]. 中华关节外科杂志(电子版), 2023, 17(06): 889-892.
[3] 刘林峰, 王增涛, 王云鹏, 钟硕, 郝丽文, 仇申强, 陈超. 足底内侧皮瓣联合甲骨皮瓣在手指V度缺损再造中的临床应用[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 480-484.
[4] 张浩, 张万福, 韩飞, 佟琳, 王运帷, 李少辉, 陈阳, 曹鹏, 官浩. 游离组织瓣治疗无吻合血管或需困难吻合血管创面的临床进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 442-446.
[5] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[6] 陈忠垚, 陈胜灯, 李秋. 不同手术时机对原发性肝癌自发破裂出血患者远期预后的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 518-521.
[7] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[8] 唐灿, 李向阳, 秦浩然, 李婧, 王天云, 柯阳, 朱红. 原发性肝脏神经内分泌肿瘤单中心12例诊治与疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 674-680.
[9] 崔佳琪, 吴迪, 陈海艳, 周惠敏, 顾元龙, 周光文, 杨军. TACE术后并发肝脓肿的临床诊治分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 688-693.
[10] 王楚风, 蒋安. 原发性肝癌的分子诊断[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 499-503.
[11] 李双喜, 胡宗凯, 赵静, 黄洁. 肝血管瘤治疗指征及治疗策略[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 504-510.
[12] 顾娇娇, 邹燕, 陈奕辰, 黄师菊, 张慧玲, 林楠. 基于简易营养评价精法评估肝癌患者出院后营养状况及其影响因素[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 534-539.
[13] 孟令展, 李虎, 俞鹏, 于燕宾, 曹李, 翟伟, 高远, 邵艳玲, 严锦, 朱震宇. ICG荧光染色在肝癌腹腔镜解剖性肝切除术中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 557-561.
[14] 田驹, 孙伯洋, 杨荣华, 赵向前. 术中意外发现肝外胆管绒毛管状腺瘤的外科处理经验:附两例报道并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 567-571.
[15] 程相阵. 腹茧症9例诊治分析并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(9): 968-971.
阅读次数
全文


摘要